CRON Stock Chart & Stats
$3.51
$0.07(2.55%)
At close: 4:00 PM EDT
$3.51
$0.07(2.55%)
Day’s Range― - ―
52-Week Range$2.28 - $3.61
Previous Close$2.02
Volume1.22M
Average Volume (3M)858.77K
Market Cap
$1.22B
Enterprise Value$410.50M
Total Cash (Recent Filing)$797.02M
Total Debt (Recent Filing)$1.29M
Price to Earnings (P/E)17.6
Beta0.54
Next Earnings
Nov 05, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding368,412,870
10 Day Avg. Volume841,773
30 Day Avg. Volume858,771
Financial Highlights & Ratios
PEG Ratio0.83
Price to Book (P/B)0.92
Price to Sales (P/S)6.74
P/FCF Ratio6.63K
Enterprise Value/Market Cap0.34
Enterprise Value/Revenue2.29
Enterprise Value/Gross Profit5.05
Enterprise Value/Ebitda7.57
Forecast
1Y Price Target
$5.01Price Target Upside42.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.12
Revenue Forecast (FY)$150.53M
Bulls Say, Bears Say
Bulls Say
Revenue And EBITDA GrowthRecord revenue and adjusted EBITDA growth indicate stronger demand and improving operating leverage across the business. If maintained, this momentum can support reinvestment, strengthen brand distribution, and provide a more durable foundation for future profitability than the company’s earlier loss-making period.
Conservative Balance SheetExtremely low leverage gives Cronos substantial financial resilience and flexibility. A conservatively financed structure reduces interest and refinancing pressure, while allowing management to fund expansion, absorb operating volatility, or pursue opportunities without relying heavily on additional borrowing.
Brand And Market PositionSpinach is gaining share faster than its market and holds leading positions across several important product categories. This suggests meaningful brand traction and distribution strength, which can support repeat demand, improve shelf access, and make growth more durable than broad industry expansion alone.
Bears Say
Profitability Not Yet ProvenThe operating turnaround has not yet translated into consistently positive bottom-line earnings. A slightly negative TTM net margin, together with recent operating losses, means the business still needs to demonstrate that improved revenue and EBITDA can persist after all expenses and across multiple reporting periods.
Gross Margin VolatilityMargin expansion is partly supported by favorable growing conditions and product or geographic mix, rather than solely by structural efficiency gains. This creates uncertainty around earnings quality and makes future profitability more dependent on mix and seasonality until stronger margin consistency is established.
Regulatory Risk In IsraelThe investigation introduces regulatory uncertainty in a key growth market and could affect the company’s ability to compete or distribute imported products there. Even though Cronos disputes the allegations, an adverse outcome could pressure market access, pricing, or the economics of the Israel operation.
Cronos Group News
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was $2.28 and its highest was $3.61 in the past 12 months.
What is Cronos Group’s market cap?
Cronos Group’s market cap is $1.22B.
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Nov 05, 2026 which is in 5 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Aug 06, 2026. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.08.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Undervalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is 0.03.
How many shares outstanding does Cronos Group have?
Cronos Group has 368,412,870 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of $0.09 in its last earnings report, beating expectations of $0.01. Following the earnings report the stock price went up 12.868%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in CRON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.01 (42.70% Upside)
$5.01 (42.70% Upside)
Blogger Sentiment
Bullish
CRON Sentiment 75%
Sector Average 64%
Sector Average 64%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.24%
12-Months-Change
Fundamentals
Return on Equity
6.46%
Trailing 12-Months
Asset Growth
0.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cronos Group
Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the cultivation, production, and commercialization of cannabis and cannabis-infused products for both medicinal and adult-use sectors. Its comprehensive product offerings encompass dried cannabis flower, pre-rolled joints, edibles, concentrated forms, and cannabis extracts. These are distributed via wholesale partnerships and direct-to-consumer channels, prominently featuring its wellness platform, PEACE NATURALS, and its adult-use brand, Spinach. Moreover, Cronos Group exports dried cannabis and cannabis oils to international markets including Germany, Israel, and Australia. Established in 2012, the company maintains its corporate headquarters in Toronto, Canada.
CRON Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational and financial picture: record revenue, gross profit, and adjusted EBITDA, strong brand performance (notably Spinach), meaningful international growth (Israel and Germany), and a robust cash position. Key risks and headwinds include a new anti-dumping investigation in Israel, modest OpEx increases, margin variability tied to seasonality and mix, and timing uncertainty around the CanAdelaar closing. On balance, the positive operational momentum and strong financials outweigh the highlighted risks.View all CRON earnings summariesCRON Stock 12 Month Forecast
Average Price Target
$5.01
▲(42.70% Upside)
Technical Analysis
Ownership Overview
4.53% Insiders
0.66% Mutual Funds
― Other Institutional Investors
92.50% Public Companies and
Individual Investors